Navigation Links
Scientists take step toward simple and portable tuberculosis tests for developing world
Date:10/8/2009

WASHINGTON, Oct. 8Two billion people worldwide carry the pathogen that causes tuberculosis (TB), and most of them do not even know they are infected. This is because some 90 percent of people with TB have "latent" infections. They have no symptoms, they can't spread the disease to others and the bug remains dormant in their lungs -- often for years.

Detecting latent TB infections is an important public health problem because those 10 percent of people who go on to develop full-blown "active" TB will, in turn, infect another 10-15 people per year on average. Such smoldering spread is one of the reasons why TB remains the seventh-leading cause of death worldwide, killing more than 1.5 million people every year.

Now a group of researchers at Colorado State University (CSU) has demonstrated a sensitive new way to use light to detect traces of TB bacteria in fluids. Their work, described by CSU graduate student Barbara Smith at the Optical Society's (OSA) Annual Meeting, Frontiers in Optics (FiO), next week in San Jose, Calif., may one day help health care workers identify people who are latently infected. Moreover, the technology may be amenable for widespread use in the developing world, where most cases of TB occur.

What is missing from the public health tool chest, says CSU professor Diego Krapf, who led the research, is a technique that can be used to widely detect TB in those places where it is most prevalent.

Krapf, Smith and their colleagues have developed a technique that can sensitively detect different molecular markers indicating a TB infection that would be cheap to use and no harder to administer than a common pregnancy test, making it ideal for use in the developing world. The Colorado researchers envision a device that would simply require someone to smear a drop of blood or urine on a glass slide, insert it into a machine and read a simple display that would indicate whether that person is infected or not.

Such a device could easily be built with existing off-the-shelf technology, says Krapf, adding that it would be no more complicated than the internal workings of a standard DVD player. The device relies on specialized surface chemistry that avoids protein adsorption, except for those molecules that need to be detected. Then, the presence of these molecules is recorded by fluorescence using a red diode laser.

Once detected, TB infections are generally treatable with a long course of antibiotics, and one of the basic strategies behind the World Health Organization's current efforts to curb the spread of the disease worldwide is to simply find the people who are infected and get them the antibiotics they need.

The CSU development could one day play a role in curbing the spread of TB. Currently, finding people who are infected is not so simple. Doctors can spot suspected cases by taking chest X-rays, which may reveal evidence of infection in the lungs. Or they can turn to a century-old technique called a sputum smear, where a sample of coughed fluid is stained and examined under a microscope for indications of the infection. Better yet, if doctors can grow cultures of TB bacteria from lung fluid, they definitively know that a person is infected.

These tests may not detect latent TB infections, however, because people who are latently infected may not have enough bacteria in their lungs to detect. For people with latent infections, other tests exist, but they have their problems as well. A simple skin test exists, but it is only sensitive enough to detect about half of all cases, says Krapf. Other more sophisticated methods that rely upon detecting specific markers in the blood are more sensitive, but they require special facilities and training that would be far too expensive for widespread use in the developing world.

Krapf and his colleagues have been able to demonstrate the feasibility of detecting markers of TB infections at great sensitivity in saline solutions -- they were even able to detect a single molecular marker of a TB infection in solution. They have not yet built a functioning device that can detect hidden TB infections in blood or urine samples, and they have not yet tested the technology on samples collected in the field. Before any such detector is available for use in the field, it would have to be rigorously tested in clinical trials.

Moving in that direction, the team plans to do a survey of blood and urine samples from people infected with TB bacteria. This will help them conclude how sensitive they need to make any detector and which markers are the best to test.


'/>"/>

Contact: Angela Stark
astark@osa.org
202-416-1443
Optical Society of America
Source:Eurekalert

Related biology news :

1. Too much of a good thing? Scientists explain cellular effects of vitamin A overdose and deficiency
2. MDC scientists show how hematopoietic stem cell development is regulated
3. You must remember this: Scientists develop nasal spray that improves memory
4. Scientists discover clues to what makes human muscle age
5. Stimulus-funded university research addressing issues from climate change to cancer, creating jobs and training a new generation of scientists
6. Scientists join forces to explain HIV spread in Central and East Africa
7. Chinas new Climate Center welcomes citizen scientists
8. Help students think like soil scientists
9. Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells
10. 2 neuroscientists from Cold Spring Harbor Laboratory awarded transformative NIH grants
11. Scientists discover how to send insects off the scent of crops
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... PUNE, India , January 19, 2017 ... Sensor Market, Opportunities and Forecast, 2014 - 2022," the global biometric sensor ... of 9.6% from 2016 to 2022. In 2015, Asia-Pacific ... for both public and private sectors. Continue Reading ... ...
(Date:1/19/2017)... 19, 2017 Sensory Inc ., ... security for consumer electronics, and i ... and cybersecurity solutions, today announced a global partnership ... institutions worldwide to bolster security of data sensitive ... user authentication platforms they offer, innerCore now offers ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, ... panel discussions to examine vital clinical research issues such as trial performance metrics, ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the ... paper by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue ... Bik joined uBiome in October 2016 from her previous position at Stanford University ...
(Date:1/18/2017)... Jan. 18, 2017 Shareholder rights law firm ... whether the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... connection with the proposed sale of the Company to ... that develops small molecules for the acute treatment of ... it had signed a definitive merger agreement with Eli ...
(Date:1/18/2017)... IRVING, Texas , Jan. 18, 2017 /PRNewswire/ ... science, and the Lustgarten Foundation, the largest private ... support a clinical trial evaluating the impact of ... is providing clinical trial enrollment services to identify ... and facilitate communication between treating physicians and study ...
Breaking Biology Technology: